Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Bispebjerg Hospital

Status and phase: Unknown; Phase 3

Conditions: Basal Cell Carcinoma

Treatments: Drug: Calcium chloride

Study type: Interventional

Funder types: Other

Identifiers

NCT05046262

EudraCT 2019-002730-36

Details and patient eligibility

About

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Full description

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation, if partial or no response after 3 months the treatment was repeated. Follow-up 3 and 12 months after last treatment.

Enrollment: 25 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Primary low risk basal cell carcinoma less than 3 cm in diameter

Exclusion criteria

Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)